Tardive Dyskinesia: Finally Some Good News
We’ve been waiting since 1953, the year chlorpromazine was introduced to the US as a revolutionary treatment for schizophrenia, for an active treatment for tardive dyskinesia that the FDA judged to be effective.
The Wandering Woman: A Pituitary Tumor
How does a pituitary result in a psychiatric emergency? Read more clues to this clinical puzzle.
Treatment of Metabolic Risk Factors in Patients With Psychotic Disorders
Despite increasing awareness of the cardiovascular risks, adequate treatment of the metabolic syndrome remains a persistent challenge.
The Clozapine-Infection Connection
Monitoring patients for 5 key changes can help avert drug toxicity.
Assisted Outpatient Treatment Enters the Mainstream
Here: common misconceptions about assisted outpatient treatment--and how this tool can help selected mentally ill patients who are most difficult to treat.
Therapy for Cognition: Restoring the Self in Bipolar Disorder
Functional remediation therapy addresses the cognitive problems of the nearly 50% of patients who remain impaired even when euthymic.
Marijuana and the Psychiatric Patient
Marijuana-related problems fall well within the scope of psychiatric practice: many patients use marijuana, which is likely to affect their psychiatric symptoms and response to treatment.
By clicking Accept, you agree to become a member of the UBM Medica Community.